The Lip TV News: Neil Riordan, PhD on Exploring New Stem Cell Treatments for MS, Arthritis, Autism and More

Stem cell treatment and research towards curing illness--from multiple sclerosis to spinal injury--is detailed by Dr. Neil Riordan. The American medical industry, obstructions to research in the states, misconceptions about stem cells, and the details about the treatment process are explained--and we look at video of patient recovery and speculate at what the future could [...]

Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic

Leo Bockeria, Vladimir Bogin, Olga Bockeria, Tatyana Le, Bagrat Alekyan, Erik J Woods, Amalia A Brown, Thomas E Ichim and Amit N Patel Journal of Translational Medicine 2013, 11:56 doi:10.1186/1479-5876-11-56 Published: 5 March 2013 Heart failure is one of the key causes of morbidity and mortality world-wide. The recent findings that regeneration is possible in [...]

Endometrial Stem Cells Yeild Postive Clinical Trial Results for Heart Disease

More progress reported on the treatment of heart disease with endometrial stem cells. Neil Riordan, PhD is one of the early pioneers of endometrial stem cell technology. Dr. Riordan is also the Founder and President of the Stem Cell Institute in Panama City, Panama. Positive Two-Month Data From RECOVER-ERC Congestive Heart Failure Trial SAN DIEGO, [...]

2012-06-06T17:50:59+00:00June 6th, 2012|Adult Stem Cells, Heart Disease, News, Stem Cell Research|

Making Blood Cells into Heart Cells

Vojdani et al. Hum Cell. 2011 Mar;24(1):35-42 One of the major debates in the area of stem cell therapy is whether adult stem cells are capable of directly transforming (differentiating) into new tissue, or whether the therapeutic effects of administered stem cells occur because of growth factors produced by the injected stem cells. There are [...]

2012-03-31T19:56:18+00:00March 31st, 2012|Heart Disease, News, Stem Cell Research|

New stem cell study promises to heal the heart

Miami Herald, Fred Tasker ftasker@MiamiHerald.com University of Miami cardiologist led by Dr. Joshua Hare reported success in a small, preliminary human clinical trial of a new stem cell therapy they hope some day will routinely mend human hearts and reduce the need for lifelong medication, possibly even for transplants. The study was published in the [...]

2012-03-17T20:13:28+00:00March 17th, 2012|Clinical Trials, Heart Disease, News, Stem Cell Research|

Medistem Begins Phase II Clinical Trial for Heart Failure

Medistem Inc announced today treatment of 3 heart failure patients in the Non-Revascularizable IschEmic Cardiomyopathy treated with Retrograde COronary Sinus Venous DElivery of Cell TheRapy (RECOVER-ERC) trial. The trial is aimed at assessing safety and efficacy of the company's Endometrial Regenerative Cell (ERC) stem cell product in 60 heart failure patients who have no available [...]

2012-01-30T18:42:22+00:00January 30th, 2012|Adult Stem Cells, Heart Disease, News, Stem Cell Research|

Bone Marrow Stem Cells Significantly Improve Cardiac Mortality Rate in Heart Disease Patients

Texas Heart Institute researcher, Emerson Perin MD, PhD revealed that heart patients who were treated with bone marrow-derived adult stem cells died at a significantly lower rate that those who did not receive stem cells. Dr. Perin's scientific findings represent yet another positive step in the ongoing fight against heart disease. Dr. Perin is the [...]

2012-01-25T18:44:01+00:00January 25th, 2012|Adult Stem Cells, Heart Disease, News, Stem Cell Research|

The Role of Adult Stem Cells in Angioplasty

The National Institute of Health has granted the Creighton School of Medicine $3.3 million dollars to study repairing damaged coronary arteries with adult stem cells. Such damage can occur when patients undergo coronary artery angioplasty and stenting. A serious problem that occurs is the re-narrowing (restenosis) of coronary arteries after stent placement. Stents are used [...]

2012-01-24T18:48:50+00:00January 24th, 2012|Adult Stem Cells, Heart Disease, News, Stem Cell Research|

Medistem and Licensee ERCell Receive Russian Regulatory Approval for the RECOVER-ERC Trial

The clinical trial, Non-Revascularizable IschEmic Cardiomyopathy treated with Retrograde COronary Sinus Venous DElivery of Cell TheRapy (RECOVER-ERC), is being led by Principle Investigator Dr. Leo Bockeria, Chairman of the Backulev Center http://www.bakulev.ru/en/about/director/. The Backulev Center is Russia's premier institute for cardiovascular surgery and cardiology. Every year the Backulev Center performs approximately 30,000 diagnostic and treatment [...]

2012-01-24T18:45:51+00:00January 24th, 2012|Adult Stem Cells, Heart Disease, News, Stem Cell Research|